Merck CEO Belén Garijo exits in 2026, leaving her next move a mystery
Belén Garijo, the outgoing CEO of Merck, will step down in April 2026. Her future role remains unknown, as there are no public details about her next position. Garijo, a physician by training, has led Merck since 2021 and plans to take a break after her departure.
Garijo believes in the importance of a strong Germany for Europe's influence globally, given the power of the U.S. and China. She dismisses the idea of decoupling Europe's industry from China, stating it's impractical and crucial for global trade. Under her leadership, Merck, operating in Europe, China, and the U.S., has expanded risk management to navigate global uncertainties.
Garijo views Germany more optimistically than many locals. She praises Chancellor Friedrich Merz's government for instilling economic confidence but stresses the need for swift action on its plans.
Belén Garijo, stepping down from Merck in April 2026, leaves her future role uncertain. She believes in Germany's and Europe's global importance, advocating for a strong Germany and practical relations with China. Her optimism about Germany's economic prospects under Chancellor Merz's leadership is tempered by a call for swift action on government plans.
Read also:
- American teenagers taking up farming roles previously filled by immigrants, a concept revisited from 1965's labor market shift.
- Weekly affairs in the German Federal Parliament (Bundestag)
- Landslide claims seven lives, injures six individuals while they work to restore a water channel in the northern region of Pakistan
- Escalating conflict in Sudan has prompted the United Nations to announce a critical gender crisis, highlighting the disproportionate impact of the ongoing violence on women and girls.
